Copyright
©The Author(s) 2016.
World J Gastrointest Pathophysiol. Nov 15, 2016; 7(4): 300-306
Published online Nov 15, 2016. doi: 10.4291/wjgp.v7.i4.300
Published online Nov 15, 2016. doi: 10.4291/wjgp.v7.i4.300
Figure 3 Inhibitory effect of calcium-glycomacropeptide-N-acetylneuraminic acid on Helicobacter pylori in vivo.
Antibiotic doses are described in the “materials and methods” section. A: Schematic design of in vivo study; B: Weight changes of mice. HP: Helicobacter pyroli; S-NANA: Standard N-acetylneuraminic acid; G-NANA: Glycomacropeptide-N-acetylneuraminic acid; CaG-NANA: Calcium-glycomacropeptide-N-acetylneuraminic acid.
- Citation: Rhee YH, Ku HJ, Noh HJ, Cho HH, Kim HK, Ahn JC. Anti-Helicobacter pylori effect of CaG-NANA, a new sialic acid derivative. World J Gastrointest Pathophysiol 2016; 7(4): 300-306
- URL: https://www.wjgnet.com/2150-5330/full/v7/i4/300.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v7.i4.300